Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World's First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

Published on January 7, 2025

million grant from the Bill & Melinda Gates Foundation that brings total grant funding from the organization to $43 million. The grant will

Continue reading on website
Other news

Main Street Announces Exit of Portfolio Investment

January 7, 2025
and equity financing alternatives within its lower middle market investment strategy. Main Street seeks to partner with private equity fund

Four years into the Next Generation EU programme: an updated preliminary evaluation of its economic impact

January 7, 2025
which occurred after the inception of the programme. In the case of investment financing grants, which are the most relevant in terms of the